ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,848.10
-0.05%
S&P ASX All Technology
3,074.90
-0.10%
Brent Oil
82.235
-0.25%
US Dollar vs AUD
1.50173
0.12%
Bitcoin
69,966.39
-0.24%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Renalytix PLC (RNLX)

  7. Renalytix PLC (RNLX) News

RNLX

Renalytix (RNLX)

Renalytix PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RNLX
DateTimeSourceHeadlineSymbolCompany
16/05/202400:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RNLXRenalytix PLC
15/05/202423:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
15/05/202421:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNLXRenalytix PLC
15/05/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
15/05/202421:00GlobeNewswire Inc.Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024NASDAQ:RNLXRenalytix PLC
09/05/202421:00GlobeNewswire Inc.Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15NASDAQ:RNLXRenalytix PLC
08/04/202421:00GlobeNewswire Inc.Renalytix Announces Financing with Expected Size of up to $4 MillionNASDAQ:RNLXRenalytix PLC
14/03/202422:00GlobeNewswire Inc.KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)NASDAQ:RNLXRenalytix PLC
15/02/202423:00GlobeNewswire Inc.Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024NASDAQ:RNLXRenalytix PLC
15/02/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
15/02/202408:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNLXRenalytix PLC
10/02/202401:00GlobeNewswire Inc.Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:RNLXRenalytix PLC
17/01/202423:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
10/01/202423:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
10/01/202423:00GlobeNewswire Inc.New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney diseaseNASDAQ:RNLXRenalytix PLC
30/12/202308:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
18/11/202308:01Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:RNLXRenalytix PLC
14/11/202323:00GlobeNewswire Inc.Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024NASDAQ:RNLXRenalytix PLC
07/11/202323:00GlobeNewswire Inc.Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14NASDAQ:RNLXRenalytix PLC
04/11/202307:04Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RNLXRenalytix PLC
24/10/202323:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
06/10/202322:00GlobeNewswire Inc.US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to RenalytixNASDAQ:RNLXRenalytix PLC
28/09/202321:00GlobeNewswire Inc.Renalytix Reports Full Year Fiscal 2023 ResultsNASDAQ:RNLXRenalytix PLC
25/09/202321:00GlobeNewswire Inc.Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28NASDAQ:RNLXRenalytix PLC
09/09/202306:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
07/09/202321:00GlobeNewswire Inc.Renalytix Appoints Senior Executive Howard Doran as Chief Business OfficerNASDAQ:RNLXRenalytix PLC
03/08/202321:00GlobeNewswire Inc.Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkdNASDAQ:RNLXRenalytix PLC
21/07/202321:00GlobeNewswire Inc.Renalytix Announces Middle East Distribution Agreement with Vector PharmaNASDAQ:RNLXRenalytix PLC
07/07/202321:00GlobeNewswire Inc.Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific SessionsNASDAQ:RNLXRenalytix PLC
03/07/202321:00GlobeNewswire Inc.Renalytix Appoints Financial Executive Catherine Coste to its Board of DirectorsNASDAQ:RNLXRenalytix PLC
 Showing the most relevant articles for your search:NASDAQ:RNLX

Your Recent History

NYSE
MCD
McDonalds
SPI
SP500
S&P 500
NYSE
XOM
Exxon Mobil
FX
AUDCAD
AUD vs CAD
ASX
XTO
S&P ASX 100
FX
AUDJPY
AUD vs Yen
ASX
SUN
Suncorp
ASX
XFL
S&P ASX 50
ASX
XMM
S&P ASX 300 Metals and M...
FTSE
UKX
FTSE 100
NYSE
NKE
Nike
ASX
WPL
Woodside Petroleum
ASX
FMG
Fortescue
CCOM
SILVER
SILVER
FX
GBPAUD
Sterling vs AUD
ASX
MQG
Macquarie
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved